Cargando…

Characterization of a New Human Embryonal Rhabdomyosarcoma Cell Line, RMS‐GR

A human tumor cell line designated RMS‐GR was established from an embryonal rhabdomyosarcoma. The monolayer cells were polygonal, round or spindle‐shaped. The RMS‐GR cell line became stable with a doubling time of 42 h. Tumorigenicity of the cells was confirmed by hetero‐transplantion into nude mice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández, Juan Emilio, Prados, Jose, Melguizo, Consolación, Arena, Nicola, Malavasi, Fabio, Álvarez, Luis, Aránega, Antonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1998
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921857/ https://www.ncbi.nlm.nih.gov/pubmed/9685856 http://dx.doi.org/10.1111/j.1349-7006.1998.tb03293.x

Ejemplares similares

Multidrug Resistance Phenotype in the RMS‐GR Human Rhabdomyosarcoma Cell Line Obtained after Polychemotherapy
por: Prados, Jose, et al.
Publicado: (1999)

Modulation of Myogenic Differentiation in a Human Rhabdomyosarcoma Cell Line by a New Derivative of 5‐Fluorouracil (QF‐3602)
por: Marchal, Juan Antonio, et al.
Publicado: (2000)

GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells
por: Marchal, J A, et al.
Publicado: (1999)

Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.
por: Kubo, K., et al.
Publicado: (1991)

Retrospective analysis of rhabdomyosarcoma (RMS) in children in a single center
por: Li, Meng, et al.
Publicado: (2018)

Modulation of MDR1 and MRP3 Gene Expression in Lung Cancer Cells after Paclitaxel and Carboplatin Exposure
por: Melguizo, Consolación, et al.
Publicado: (2012)

Baseline Characteristics, Prognostic Factors, and Treatment Outcomes for Adult Patients With Rhabdomyosarcoma (RMS)
por: Rab, Saif ur, et al.
Publicado: (2022)

Nanomedicine: Application Areas and Development Prospects
por: Boulaiz, Houria, et al.
Publicado: (2011)

Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript
por: Colletti, Marta, et al.
Publicado: (2021)

5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
por: Ortiz, Raúl, et al.
Publicado: (2012)

gef Gene Expression in MCF-7 Breast Cancer Cells is Associated with a Better Prognosis and Induction of Apoptosis by p53-Mediated Signaling Pathway
por: Boulaiz, Houria, et al.
Publicado: (2011)

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
por: van Erp, Anke E. M., et al.
Publicado: (2017)

Outcome and prognostic variables in childhood rhabdomyosarcoma (RMS) with emphasis on impact of FOXO1 fusions in non-metastatic RMS: experience from a tertiary cancer centre in India
por: Ramanathan, Subramaniam, et al.
Publicado: (2023)

Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG‐RMS2005 study
por: Terwisscha van Scheltinga, Sheila E. J., et al.
Publicado: (2020)

Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence
por: Li, Jenny J., et al.
Publicado: (2021)

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
por: Melguizo, Consolación, et al.
Publicado: (2012)

Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS
por: Ciarapica, Roberta, et al.
Publicado: (2014)

Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell Death
por: Schott, Christina, et al.
Publicado: (2015)

Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS)
por: Lacey, Alexandra, et al.
Publicado: (2016)

Uterine cavity embryonal rhabdomyosarcoma
por: Sardinha, Marina Gomes Pereira, et al.
Publicado: (2019)

Meroxest improves the prognosis of immunocompetent C57BL/6 mice with allografts of E0771 mouse breast tumor cells
por: Carrasco, Esther, et al.
Publicado: (2016)

Registration Management System (RMS)
por: Epting, U
Publicado: (1999)

Re: CaRMS at 50
por: MacFarlane, Malcolm
Publicado: (2020)

Embryonal rhabdomyosarcoma of the broad ligament
por: Chandarana, Mihir N., et al.
Publicado: (2014)

Defining an embryonal rhabdomyosarcoma endotype
por: Ricker, Cora A., et al.
Publicado: (2020)

Embryonal Rhabdomyosarcoma of the Tongue in Adults
por: Díez-Montiel, Alberto, et al.
Publicado: (2023)

Pediatric laryngeal embryonal rhabdomyosarcoma()
por: Lupoli, Bruna de Alencar Custodio, et al.
Publicado: (2023)

Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies
por: Martín-Banderas, Lucía, et al.
Publicado: (2012)

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
por: Perazzoli, Gloria, et al.
Publicado: (2015)

RMS envelope equations with space charge
por: Sacherer, F J
Publicado: (1970)

RMS envelope equations with space charge
por: Sacherer, Franck J
Publicado: (1971)

Systematic errors on r.m.s. computation
por: Hémery, J-Y
Publicado: (1991)

Embryonal Rhabdomyosarcoma in a Young Boy
por: Ng, Wendy Kar Yee
Publicado: (2007)

Congenital embryonal rhabdomyosarcoma; multiple lesions
por: Esmaeili, Heidarali, et al.
Publicado: (2017)

Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2019)

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
por: Oliver, Jaime Antonio, et al.
Publicado: (2014)

Synthetic Circular miR-21 Sponge as Tool for Lung Cancer Treatment
por: Rama, Ana R., et al.
Publicado: (2022)

Botryoid embryonal rhabdomyosarcoma of the cervix: A case report
por: Hermoza, Alejandro Delfos, et al.
Publicado: (2022)

Final setting up cycle of RMS at NIMROD
por: CERN. Geneva. Proton Synchrotron and Synchrocyclotron Committee
Publicado: (1977)

Variable Resistance of RMS to Interferon γ Signaling
por: Simon-Keller, Katja, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kjr319s0rrmch5ej7moi6trcva